Revised Schedule M Implementation in Indian Pharma: Impact, Compliance Status & Industry Outlook (Deadline: 31 December 2025)
Introduction The Indian pharmaceutical industry is at a critical regulatory crossroads with the revised Schedule...
India’s drug watchdog launches digital tracker for cough syrup ingredients
India has introduced a digital monitoring system to track high-risk solvents used in cough syrups...
